Viewing Study NCT06928818


Ignite Creation Date: 2025-12-25 @ 4:52 AM
Ignite Modification Date: 2026-03-18 @ 8:06 PM
Study NCT ID: NCT06928818
Status: RECRUITING
Last Update Posted: 2025-04-17
First Post: 2025-03-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea
Sponsor: Seoul National University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module